Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thibault Mesplede

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2024
Insights in Dolutegravir-Resistance PathwaysThibault Mesplede, Pierre Gantner
Journal of the International AIDS Society|December 8, 2015
Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapyMark A Wainberg, Thibault Mesplede
Retrovirology|June 7, 2017
HIV drug resistance against strand transfer integrase inhibitorsKaitlin Anstett, Bluma Brenner, Thibault Mesplede, et al.
Journal of Virology|February 6, 2015
Dolutegravir resistance mutation R263K cannot coexist in combination with many classical integrase inhibitor resistance substitutionsKaitlin Anstett, Thibault Mesplede, Maureen Oliveira, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2014
The R262K substitution combined with H51Y in HIV-1 subtype B integrase confers low-level resistance against dolutegravirVincent Cutillas, Thibault Mesplede, Kaitlin Anstett, et al.
Journal of the International AIDS Society|November 14, 2014
The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compoundMark Wainberg, Kaitlin Anstett, Thibault Mesplede, et al.
Journal of Virological Methods|May 16, 2012
A high-throughput assay for HIV-1 integrase 3'-processing activity using time-resolved fluorescenceYing-Shan Han, Peter Quashie, Thibault Mesplede, et al.
Journal of Virology|November 11, 2011
IκB kinase ε-dependent phosphorylation and degradation of X-linked inhibitor of apoptosis sensitizes cells to virus-induced apoptosisPeyman Nakhaei, Qiang Sun, Mayra Solis, et al.
European Journal of Immunology|January 20, 2007
Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophagesMayra Solis, Raphaëlle Romieu-Mourez, Delphine Goubau, et al.
Journal of Virology|April 18, 2008
Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiationStephanie Oliere, Meztli Arguello, Thibault Mesplede, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2024
Insights in Dolutegravir-Resistance PathwaysThibault Mesplede, Pierre Gantner
Journal of the International AIDS Society|December 8, 2015
Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapyMark A Wainberg, Thibault Mesplede
Retrovirology|June 7, 2017
HIV drug resistance against strand transfer integrase inhibitorsKaitlin Anstett, Bluma Brenner, Thibault Mesplede, et al.
Journal of Virology|February 6, 2015
Dolutegravir resistance mutation R263K cannot coexist in combination with many classical integrase inhibitor resistance substitutionsKaitlin Anstett, Thibault Mesplede, Maureen Oliveira, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2014
The R262K substitution combined with H51Y in HIV-1 subtype B integrase confers low-level resistance against dolutegravirVincent Cutillas, Thibault Mesplede, Kaitlin Anstett, et al.
Journal of the International AIDS Society|November 14, 2014
The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compoundMark Wainberg, Kaitlin Anstett, Thibault Mesplede, et al.
Journal of Virological Methods|May 16, 2012
A high-throughput assay for HIV-1 integrase 3'-processing activity using time-resolved fluorescenceYing-Shan Han, Peter Quashie, Thibault Mesplede, et al.
Journal of Virology|November 11, 2011
IκB kinase ε-dependent phosphorylation and degradation of X-linked inhibitor of apoptosis sensitizes cells to virus-induced apoptosisPeyman Nakhaei, Qiang Sun, Mayra Solis, et al.
European Journal of Immunology|January 20, 2007
Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophagesMayra Solis, Raphaëlle Romieu-Mourez, Delphine Goubau, et al.
Journal of Virology|April 18, 2008
Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiationStephanie Oliere, Meztli Arguello, Thibault Mesplede, et al.
Pageof 2